Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-417970

CEO acquired 23,564 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Weis Holger CEO 2026-10-06 Grant or award +23,564 $0.74 $17,541 49,047 D: show line 1 in the form
Loading xslF345X06/ownership.xml…